Answers are grounded in this paper and cite their sources.
Suppl Table S1. Clinical characteristics of metastatic patient cohort Suppl Table S2. The 361 gene signature identified in this study to classify T-cell immune clusters Suppl Table S3. The 80 immune and stroma related gene signatures used to quantify the TME Suppl Table S4. DEGs for SCLC versus NEPC tumors Suppl Table S5. NCI-Nature_2016 pathways enriched in the DEGs from SCLC vs NEPC
No takes yet. Share an insight, caveat, or question.
Bhinder et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: